Pfizer executives said most patients experienced few or mild side effects, with gastrointestinal events largely limited ​to ...

For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss.

Pfizer Inc. is pulling back the curtain on its obesity ambitions, releasing new data on an experimental weight-loss shot and outlining a strategy to claw its way into a leadership position in the ...